Rigel Pharmaceuticals logo

Rigel Pharmaceuticals

RIGL | NASDAQ
Chart Builder DCF Calculator
$43.73
-$0.73 (-1.64%)
At close: Nov 16, 2026, 4:00 PM ET
$43.73
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET
-1.64%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
72
Fundamentals Excellent
Market Sentiment Neutral
Moat Narrow
Sector Rank #43/1021 (Top 4%)

Key Statistics

Market Data

Market Cap $823.43M
1D Range
43.36 45.70
52W Range
25.44 51.45

Valuation (TTM)

PE 2.82
PB 1.85
EV/EBITDA 8.78

Valuation (NTM)

Forward PE 13.60
Forward PEG -0.05
Price Target $67.00
Loading financial charts...

Profile

Rigel Pharmaceuticals, Inc., a biotechnology company, develops and provides therapies that enhance the lives of patients with hematologic disorders and cancer in the United States. The company offers ...

Sector Healthcare
Industry Biotechnology
Employees 173
IPO Date Nov 29, 2000
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Nov 5, 2026
EPS
$0.65
Miss -25.29%
REV
$80.89M
Beat +1.12%
Next Earnings
Mar 2, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
4
Consensus
Hold
Price Target
$67.00
Upside
+53.21%
Buy (2)
Hold (2)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.